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Objectives
There is a high prevalence of HIV (5.2% in 2018) among men who have sex with men (MSM) in
Ukraine. HIV testing, condom provision and facilitated linkage to HIV treatment have been funded
by various bodies through non-governmental organizations (NGOs). We investigated whether
contact with these NGOs was associated with improved prevention and treatment outcomes among
MSM in Ukraine.
Methods
Data were taken from four rounds of integrated bio-behavioural surveys among MSM in Ukraine
(2011, N = 5950; 2013, N = 8101; 2015, N = 4550; 2018, N = 5971) including HIV testing
combined with questionnaire responses. Data were analysed using mixed-effect regression models,
which estimated associations between being an NGO client and behavioural, HIV testing and HIV
treatment outcomes, adjusted for demographic factors.
Results
Those MSM who were NGO clients were more likely than non-clients to have been HIV tested in
the last year [adjusted odds ratio (aOR) = 7.01, 95% confidence interval (CI): 6.45–7.62] or ever
(aOR = 11.00, 95% CI: 9.77–12.38), to have used a condom for the last anal sex act (aOR = 1.32,
95% CI: 1.21–1.43), and to have recently either bought or received condoms (aOR = 21.27, 95% CI:
18.01–25.12). HIV-positive MSM were more likely to have contact with NGOs (aOR = 1.61, 95% CI:
1.39–1.86). Among the HIV-positive MSM, those who were NGO clients were more likely to be
registered at an AIDS centre (aOR = 2.24, 95% CI: 1.61–3.11) and to be on antiretroviral treatment
(aOR = 2.20, 95% CI: 1.51–3.20).
Conclusions
In Ukraine, being in contact with MSM-targeted NGOs is associated with better outcomes for HIV
prevention, testing and treatment, suggesting that NGO harm reduction projects for MSM have had
a beneficial impact on reducing HIV transmission and morbidity.
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Introduction
Globally, there is consistent evidence that men who have
sex with men (MSM) are at substantial risk of HIV
infection due to a high prevalence of HIV and a height-
ened probability of transmission through unprotected
anal intercourse [1]. In eastern Europe and Central Asia,
the region reporting the fastest-growing HIV epidemic in
the world [2], HIV prevalence among MSM has been esti-
mated at 6.6%, with over a fifth of all incident cases in
the region occurring among MSM [1,3]. Ukraine is the
second largest country in this region and has the second
largest HIV burden [4], with an estimated 240 000 people
living with HIV (PLWH) and an estimated 12 000 new
HIV infections occurring annually [5]. HIV prevalence is
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estimated at 8.5% among the 181 000 MSM in Ukraine,
suggesting that MSM account for c. 6.4% of PLWH in
Ukraine [6].
Both globally and in Ukraine, MSM require interven-
tions specifically targeted for the prevention and treat-
ment of HIV, particularly condom distribution and
antiretroviral therapy (ART) for HIV, to control their high
HIV prevalence and incidence. Pre-exposure prophylaxis
(PrEP) is also effective at preventing HIV transmission [7]
but is not yet readily available in Ukraine [5]. While con-
dom use can partially reduce the risk of HIV transmission
[8], ART can effectively halt HIV transmission by reduc-
ing viral loads to undetectable levels [9]. Life expectan-
cies for PLWH who are taking long-term ART are
approaching those of the HIV-negative general popula-
tion in some countries [10], while morbidity for those
taking ART has drastically reduced [11]. For HIV-positive
MSM to initiate ART requires them to be diagnosed and
linked to care, requiring high testing coverage.
In Ukraine, most funding for HIV treatment and pre-
vention has come from funding organizations such as the
Global Fund to Fight AIDS, Tuberculosis and Malaria,
with most funds going to non-governmental organiza-
tions (NGOs), e.g. the Alliance for Public Health (APH)
and 100% Life [12]. The purpose of these NGOs is to
reduce the epidemics of HIV and other infectious diseases
among Ukraine’s most vulnerable populations, including
MSM, and their activities include condom distribution,
HIV testing and counselling, and linkage to ART, which
is provided by government-run AIDS centres. Recently,
expectations that governments of middle-income country
settings can and should fund their own interventions for
HIV, hepatitis C virus and tuberculosis has led to global
funders reducing their provision of funds to these set-
tings, including Ukraine, where the latest Global Fund
grant supports the transition of prevention services to the
Ukrainian government [13] – from November 2019, core
prevention activities, including testing and condom pro-
vision, have been supported by the government. These
reductions, paired with a recent economic crisis and war
with Russia, could lead to reductions in services provided
to MSM and other key populations [14]. It is therefore
important to show whether current services for MSM are
having an impact and should therefore have continued
support.
The APH has undertaken multiple rounds of nationwide
cross-sectional integrated bio-behavioural surveys (IBBSs)
among MSM to estimate and assess changes in risk beha-
viours and the coverage of prevention, testing and treat-
ment interventions among MSM, and to monitor the
dynamics of the HIV epidemic. We aimed to use data
from these surveys, undertaken between 2011 and 2018,
to examine whether being a client of an MSM-targeted
NGO in Ukraine is associated with improved HIV preven-




We used data from four nationwide IBBSs for MSM in
Ukraine covering the years 2011, 2013, 2015 and 2018,
which recruited MSM using respondent-driven sampling
(RDS), with full details of the sampling methodology
given in the survey reports [15–18]. Eligible participants
reported at least one sexual (oral, anal) contact with
another man in the past 6 months, were aged ≥ 14 years,
and resided in a participating city. They needed to give
consent to being surveyed, provide a dried blood spot
sample, and agree to HIV testing. A person could partici-
pate in multiple rounds of the survey; however, there was
no linkage ID between surveys so longitudinal outcomes
of participants could not be assessed. The surveys
included 28 cities, encompassing all of Ukraine’s regions.
The surveys were carried out in different venue types,
mostly rented office blocks, AIDS centres and, in some
cases, the offices of NGOs.
Participants were asked about demographic characteris-
tics, sexual behaviours, harm reduction intervention con-
tact and outcomes, recent contact and duration of contact
with NGOs, HIV testing history, self-reported HIV diagno-
sis status, HIV treatment uptake and knowledge of HIV
transmission. The questions included in each survey were
similar across rounds but there were some minor differ-
ences, and, in some years, particular questions were
added or excluded. Our analyses mostly focus on ques-
tions that are comparable across all rounds. In the 2018
survey, questions about PrEP were added. The question
‘Are you a client of any non-governmental organization
(have a card or an individual code) that provides preven-
tion services for men who have sex with men?’ was used
to ascertain whether someone was a client of an NGO.
HIV testing using rapid tests (dried blood spot) was
performed in each survey to determine a respondent’s
HIV status. Hepatitis C virus and syphilis were also tested
for, but these results are not considered in this study,
which focused on HIV.
Analyses
All analyses were carried out in Stata 15.1. RDS weights
were not used in the main analysis due to a lack of con-
sensus around their validity in regression models [19],
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particularly when RDS surveys across multiple sites are
combined. However, we present RDS-weighted character-
istics for comparison in sensitivity analyses.
Trends over time
Trend tests for variables across multiple survey years
were performed using logistic or linear regression,
depending on whether the outcome variable was binary
or continuous, with cluster-robust standard errors being
used for clustering by city. Time was included as a con-
tinuous variable.
Comparing MSM by NGO client status
Tests for differences in behaviours and preventive out-
comes by current NGO client status (combined over all
the years) were assessed by either v2 or t-tests, depending
on whether the variable was binary or continuous.
Characteristics associated with being an NGO client
We tested for general non-intervention-related character-
istics associated with being an NGO client (vs. not), using
mixed-effect logistic regression with city and year as the
crossed random-effects. In unadjusted and adjusted anal-
yses, we investigated whether testing HIV-positive (vs.
negative), age (years), having ever been imprisoned (vs.
not), education level (categorical), being transgender,
having provided sex for money in the last 6 months,
having had sex with a woman in the last 6 months, and
total number of anal sex partners in the last month were
associated with being an NGO client. Data from 2011
were excluded as the question on being transgender was
not available for that year.
Associations between being an NGO client and
intervention-related outcomes
To assess for associations between NGO client status and
various intervention-related outcomes around HIV trans-
mission, we used mixed-effect logistic regression models
with city and year as the crossed random effects. Unad-
justed and adjusted associations of the outcomes with
NGO client status, while adjusting for age, having ever
been imprisoned, higher education level, group sex in the
last 6 months, chemsex in the last 6 months, being trans-
gender, having had sex with a woman in the last
6 months, and total number of anal sex contacts in the
last month were assessed. Model fit was assessed by
observing the pseudo-R2 values.
Cascade of care
Data from the earliest and most recent surveys (2011 and
2018) were used to create HIV cascades of care to com-
pare the outcomes over the two time points. The cascades
included the number of MSM testing HIV-positive, the
number self-reporting being HIV-positive, the number
reporting being registered at an AIDS centre (a require-
ment for receipt of ART in Ukraine), and the number
reporting that they receive ART. Differences in the HIV
cascade of care stages by whether MSM were NGO clients
or not were assessed using v2 tests.
Ethical approval
All procedures involving human participants were per-
formed in accordance with the 1964 Helsinki Declaration
and its later amendments or comparable ethical stan-
dards. The surveys were examined by the Committee of
Medical Ethics from the Institute of Epidemiology and
Infectious Diseases of the Ukrainian Academy of Medical
Sciences. Informed consent was obtained from all study
participants.
Results
Trends over time and overall values across the survey
years for various demographic, behavioural and HIV-re-
lated variables are shown in Table 1. Table S1 shows the
same breakdown of results by year using RDS weights,
giving similar results. In all, 5950 MSM were sampled in
2011, 8101 in 2013, 4550 in 2015, and 5971 in 2018.
Overall, around 31% of MSM surveyed were NGO clients.
The mean age of those surveyed was 29 years. The per-
centage of clients who self-reported using a condom dur-
ing their last anal sex with a male partner was 73.3%
(83.9% for the last casual partner), whilst 50.5% self-re-
ported always using condoms for anal sex over the previ-
ous 30 days. Overall, 3.6% had been imprisoned at some
time, 33.3% had higher education, and 23.8% had had
sex with a woman in the last 12 months. The mean total
number of anal sex partners reported in the last 30 days
was 2.6. Around 3.4% reported that they paid another
man for anal sex within the last 30 days, whilst 4.9%
engaged in chemsex (taking drugs before sex), and 1.9%
had injected drugs at some time.
Comparing MSM by NGO client status
There were differences in the characteristics and beha-
viours of NGO and non-NGO clients for many of the
© 2020 The Authors.
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variables assessed (Table 2). These included the mean
number of anal sex partners in the last 30 days, the mean
number of casual anal sex partners, the mean number of
partners they paid for anal sex, the mean number of part-
ners who paid them for anal sex, and the proportions
reporting using a condom for their last anal sex act that
they bought. NGO clients were more likely to have used a
condom during their last anal sex act with a male partner
and for each type of partner (except when buying anal
sex). NGO clients were also more likely to report always
using condoms for anal sex in the previous 30 days and
to have ever provided sex for money. MSM were asked
about PrEP in the 2018 survey, with 896 (53.2%) NGO
clients having heard of it vs. 1001 (23.5%) non-NGO cli-
ents (P < 0.001), whilst 33 (2.2%) of HIV-negative NGO
clients reported being on PrEP in the previous year


















Test for trend over
time [coefficient
(95% CI)]* P-value
NGO client 25.8% 30.6% 41.6% 28.3% 30.9 % 0.07 (0.07–0.22) 0.323
Mean NGO client duration (months) 17.8 25.1 25.2 30.2 24.8 3.27 (1.84–5.30) < 0.001
Mean age (years) 27.6 28.4 29.4 28.9 28.5 0.47 (0.02–0.96) 0.057
Age of first sex (oral or anal) with man 17.9 17.8 18 18 17.9 0.04 (0.16–0.25) 0.663
Bisexual 31.0% 26.6% 32.2% 33.1% 30.3% 0.06 (0.02–0.14) 0.159
Transgender NA 3.1% 2.5% 2.4% 2.7% –0.13 (0.41–0.15) 0.359
Ever imprisoned 3.5% 3.5% 4.2% 3.2% 3.6% –0.02 (0.18–0.16) 0.886
Higher education 34.0% 33.0% 34.9% 31.8% 33.3% –0.02 (0.10–0.05) 0.554
Mean number of total anal sex partners in last 30 days 2.7 2.6 NA 2.4 2.6 0.12 (0.29–0.05) 0.152
Mean number of casual and permanent anal sex partners in last 30 days 2.5 2.4 2.4 2.2 2.4 –0.10 (0.25–0.06) 0.215
Mean number of permanent anal sex partners in last 30 days 0.8 0.8 0.8 0.8 0.8 0.02 (0.06–0.02) 0.349
Mean number of casual anal sex partners in last 30 days 1.7 1.6 1.6 1.4 1.6 –0.07 (0.22–0.07) 0.319
Mean number of partners they paid for anal sex in last 30 days 0.06 0.07 0.06 0.04 0.06 –0.01 (0.02–0.00) 0.22
Mean number of partners who paid them for anal sex in last 30 days 0.2 0.2 NA 0.1 0.2 –0.02 (0.06–0.01) 0.212
Percentage with no anal sex partners in the last 30 days 9.6% 10.1% 15.0% 19.5% 13.2% 0.31 (0.15–0.47) < 0.001
Condom for last anal sex with male partner 70.1% 73.4% 72.1% 77.6% 73.3% 0.11 (0.03–0.26) 0.13
Condom for last anal sex with permanent partner 62.1% 63.4% 66.2% 70.6% 65.2% 0.13 (0.03–0.29) 0.119
Condom for last anal sex with casual partner 79.2% 83.2% 87.8% 87.9% 83.9% 0.24 (0.02–0.49) 0.067
Condom for last anal sex with commercial partner (they paid) 86.4% 93.2% 91.0% 85.8% 90.2% –0.08 (0.46–0.30) 0.69
Condom for last anal sex with commercial partner (they were paid) 79.0% 77.4% 80.7% 74.7% 78.0% –0.05 (0.32–0.23) 0.744
Always used condoms for anal sex in last 30 days 47.9% 52.4% 49.6% 51.1% 50.5% 0.03 (0.12–0.17) 0.729
Ever provided sex for money NA 16.0% 16.7% 16.6% 16.3% 0.02 (0.15–0.19) 0.781
Provided sex for money in the last 6 months 10.0% 5.7% 15.1% 7.9% 9.0% 0.03 (0.08–0.15) 0.568
% bought anal sex in the last 30 days 2.7% 4.6% 3.2% 2.5% 3.4% –0.08 (0.23–0.07) 0.314
Group sex in the last 6 months NA 21.6% 23.1% 17.2% 20.5% –0.13 (0.23 to 0.02) 0.016
Percentage who had sex with a woman in last 6 months 25.8% 23.4% 23.7% 22.3% 23.8% –0.05 (0.14–0.03) 0.194
Used condom for last sex with female 66.7% 66.2% 62.0% 72.5% 69.0% 0.06 (0.05–0.17) 0.261
Chemsex in last 30 days NA 6.7% 0.9% 5.4% 4.9% –0.19 (0.49–0.11) 0.212
Ever injected drugs 2.5% 1.8% 1.6% 1.9% 1.9% –0.09 (0.36–0.18) 0.500
Suffered violence or abuse from organized movements NA NA 7.4% 7.9% 7.7% 0.07 (0.27–0.41) 0.696
Received free condoms in the last 12 months 60.1% 51.0% 52.7% 44.2% 51.9% –0.18 (0.35 to 0.02) 0.028
Bought condoms last month 31.4% 40.3% 27.7% 35.3% 34.6% –0.01 (0.12–0.11) 0.924
Received free condoms in the last 12 months or bought condoms last
month
79.5% 80.0% 74.1% 71.6% 76.7% –0.17 (0.31 to 0.02) 0.025
Ever received an HIV test 60.5% 64.3% 77.6% 65.4% 66.1% 0.12 (0.02–0.22) 0.023
HIV tested last year 41.7% 41.4% 51.4% 43.9% 43.9% 0.06 (0.04–0.16) 0.214
HIV tested by NGO last year 17.1% 21.2% 35.3% 27.1% 24.2% 0.23 (0.08–0.38) 0.002
Self-reporting HIV-positive 1.5% 1.4% 1.6% 2.5% 1.7% 0.20 (0.05–0.45) 0.124
Registered at an AIDS centre (of N = 420 self-reporting HIV-positive) 75.0% 87.7% 90.3% 91.9% 87.1% 0.33 (0.03–0.64) 0.032
On antiretroviral therapy (of N = 420 self-reporting HIV-positive) 38.9% 63.4% 36.9% 92.7% 56.4% 0.69 (0.53–0.86) <0.001
HIV-positive 6.4% 4.3% 7.8% 5.2% 5.7% –0.00 (0.12–0.12) 0.97
HIV-positive of N = 9606 aged < 25 years 4.5% 1.9% 4.3% 2.4% 3.1% –0.14 (0.32–0.04) 0.117
Registered in an AIDS centre (of N = 1393 HIV-positive) 18.8% 26.4% 18.1% 42.3% 25.8% 0.31 (0.03–0.60) 0.031
On antiretroviral therapy (of N = 1393 HIV-positive) 7.3% 17.1% 6.5% 39.1% 16.7% 0.62 (0.30–0.95) <0.001
95% CI, 95% confidence interval; NGO, non-governmental organization; NA, not available; chemsex, taking drugs (typically stimulants) before sex (ex-
cluding alcohol).
*Trend test coefficient produced using logistic or linear regression modelling (depending on variable type) with survey year as an independent variable
and clustering of standard errors by city.
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Table 2 Behaviours and preventive outcomes among men who have sex with men across each survey year and combined across survey years,
stratified by whether they are non-governmental organization (NGO) clients or not and tested for differences*
Variable




































Mean age (years) 27.7 28.3 29.2 28.3 28.3 27.6 28.6 29.8 30.5 29.1 < 0.001
Age of first sex (oral or anal) with man 18.1 18 18.2 18.1 18.1 17.3 17.4 17.6 17.6 17.5 < 0.001
Bisexual 33.6% 29.0% 36.2% 36.0% 33.1% 23.7% 21.4% 26.6% 25.8% 24.1% < 0.001
Transgender NA 2.0% 2.0% 2.1% 2.4% NA 3.5% 3.1% 3.0% 3.2% 0.002
Ever imprisoned 3.7% 3.5% 5.1% 3.4% 3.8% 3.1% 3.6% 2.9% 2.8% 3.1% 0.015
Higher education 33.4% 31.2% 32.1% 30.9% 31.8% 35.8% 37.5% 38.8% 34.1% 36.7% < 0.001
Mean number of total anal sex partners in
last 30 days
2.7 2.6 NA 2.4 2.6 2.9 2.6 NA 2.3 2.6 0.235
Mean number of casual and permanent
anal sex partners in last 30 days
2.5 2.4 2.3 2.2 2.4 2.7 2.5 2.4 2.2 2.5 0.05
Mean number of permanent anal sex
partners in last 30 days
0.8 0.8 0.7 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.003
Mean number of casual anal sex partners
in last 30 days
1.6 1.5 1.6 1.5 1.5 1.8 1.6 1.6 1.4 1.6 0.309
Mean number of partners they paid for
anal sex in last 30 days
0.05 0.07 0.07 0.05 0.06 0.07 0.06 0.04 0.02 0.05 0.132
Mean number of partners who paid them
for anal sex in last 30 days
0.2 0.2 NA 0.1 0.2 0.2 0.2 NA 0.1 0.2 0.727
Percentage with no anal sex partners in
the last 30 days
9.1% 10.3% 15.5% 19.0% 13.0% 10.7% 9.6% 14.1% 20.6% 13.4% 0.466
Condom for last anal sex with male
partner
67.4% 70.5% 70.2% 77.3% 71.3% 77.4% 79.7% 74.7% 78.4% 77.7% < 0.001
Condom for last anal sex with permanent
partner
60.7% 60.9% 63.1% 71.2% 63.6% 65.8% 68.6% 69.6% 69.3% 68.5% < 0.001
Condom for last anal sex with casual
partner
75.5% 79.4% 84.0% 86.7% 80.6% 90.3% 92.6% 93.5% 91.3% 92.1% < 0.001
Condom for last anal sex with commercial
partner (they paid)
85.5% 92.4% 91.2% 87.0% 89.7% 89.5% 95.3% 90.7% 81.3% 91.3% 0.492
Condom for last anal sex with commercial
partner (they were paid)
73.9% 76.2% 77.8% 74.7% 75.7% 89.2% 81.0% 84.8% 75.0% 83.0% 0.005
Always used condoms for anal sex in last
30 days
45.8% 49.3% 46.9% 51.1% 48.5% 53.9% 59.5% 53.3% 51.5% 55.0% < 0.001
Ever provided sex for money NA 15.6% 14.9% 16.0% 15.6% NA 16.7% 19.1% 18.2% 17.8% < 0.001
Provided sex for money in the last
6 months
9.4% 6.0% 13.3% 7.9% 8.5% 11.5% 5.1% 17.5% 7.8% 10.1% < 0.001
Percentage who bought anal sex in the
last 30 days
2.8% 4.7% 3.5% 2.7% 3.5% 2.5% 4.3% 2.9% 1.9% 3.0% 0.054
Group sex in the last 6 months NA 21.0% 21.3% 16.2% 19.5% NA 22.7% 25.7% 19.6% 22.8% < 0.001
Percentage who had sex with a woman in
last 6 months
27.9% 26.9% 27.6% 25.4% 26.9% 19.4% 15.5% 18.5% 14.5% 16.8% < 0.001
Used condom for last sex with female 64.2% 65.8% 61.7% 72.3% 66.3% 76.2% 67.8% 62.6% 73.0% 69.4% 0.042
Chemsex in last 30 days NA 7.6% 1.0% 5.7% 5.5% NA 4.6% 0.9% 4.6% 3.4% < 0.001
Ever injected drugs 2.9% 2.2% 1.7% 1.9% 2.2% 1.1% 0.7% 1.3% 2.1% 1.2% < 0.001
Suffered violence or abuse from organized
movements
NA NA 6.9% 7.6% 7.3% NA NA 8.2% 8.7% 8.4% 0.047
Received free condoms in the last
12 months
46.9% 30.4% 21.3% 24.5% 31.8% 97.3% 97.2% 96.4% 94.1% 96.3% < 0.001
Bought condoms last month 39.3% 53.1% 42.1% 44.9% 45.7% 8.7% 11.3% 7.5% 10.8% 9.7% < 0.001
Received free condoms in the last
12 months or bought condoms last
month
72.9% 72.0% 57.3% 62.1% 67.4% 98.2% 98.1% 97.5% 95.7% 97.4% < 0.001
Ever received an HIV test 51.8% 53.5% 63.9% 54.0% 54.8% 85.7% 88.7% 96.8% 94.5% 91.4% < 0.001
HIV tested last year 31.8% 29.3% 32.5% 30.7% 30.8% 70.6% 68.9% 78.0% 77.7% 73.5% < 0.001
HIV tested by NGO last year 9.6% 9.2% 12.3% 10.3% 10.1% 38.7% 48.5% 67.5% 69.5% 55.9% < 0.001
Self-reporting HIV-positive 1.0% 0.8% 1.1% 1.3% 1.0% 2.8% 2.6% 2.3% 5.4% 3.2% < 0.001
Registered at an AIDS centre (of those
self-reporting HIV-positive)
70.5% 84.1% 86.2% 87.7% 82.2% 90.5% 84.4% 90.9% 94.5% 90.5% 0.013
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compared with 43 (1.1%) HIV-negative non-NGO clients
(P = 0.001).
Non-intervention-related characteristics associated
with being an NGO client
Table 3 shows the non-intervention-related characteristics
associated with being an NGO client. In adjusted analy-
ses, HIV-positive MSM were more likely to be NGO cli-
ents than were non-NGO clients. The older the MSM, the
more likely they were to be NGO clients, while MSM with
a higher education level were also more likely to be NGO
clients. Transgender MSM were more likely to be NGO
clients, while MSM who reported sex with a woman in
the last 6 months were less likely to be NGO clients. Hav-
ing been imprisoned at some point, having provided sex
for money in the last 6 months, and the total number of
anal sex contacts in the last month were not associated
with being an NGO client in adjusted analyses.
Associations between being an NGO client and
intervention-related outcomes
Figure 1 and Tables S2 and S3 show the adjusted associa-
tions between being an NGO client and various HIV-related
intervention outcomes. Being an NGO client was positively
associated with all outcomes considered except for being
registered at an AIDS centre and being on ART among
those self-reporting as HIV-positive; however, being an
NGO client was positively associated with these two out-
comes among those testing HIV-positive. Having bought
condoms in the previous month was negatively associated
with being an NGO client [adjusted odds ratio (aOR) = 0.12,
95% confidence interval (CI): 0.11–0.13]. However, NGO
clients were more likely to have received free condoms in
the previous year (aOR = 80.78, 95% CI: 69.62–93.72), and
were also more likely to have either bought condoms in the
last month or received free condoms in the previous year
(aOR = 21.27, 95% CI: 18.01–25.12), a composite measure.
The other outcomes that were positively associated with
being an NGO client were being HIV-tested in the last year
(among those HIV-negative at the time of the survey), ever
being HIV-tested, using a condom for the last anal inter-
course (overall, with a permanent partner, or with a casual
partner), being HIV-positive, being aware of their HIV-pos-
itive status among those testing HIV-positive, being regis-
tered at an AIDS centre among those testing HIV-positive,
and being on ART among those testing HIV-positive.
Table 2 (Continued)
Variable




































On antiretroviral therapy (of those self-
reporting HIV-positive)
18.2% 50.0% 34.5% 82.5% 50.0% 45.2% 54.7% 31.8% 86.8% 61.0% 0.026
HIV-positive 5.8% 3.3% 6.9% 3.8% 4.6% 8.2% 6.4% 8.9% 8.9% 7.9% < 0.001
HIV -positive of those aged < 25 years 4.4% 1.5% 3.2% 1.5% 2.5% 4.9% 3.0% 6.3% 5.6% 4.7% < 0.001
Registered at an AIDS centre (of those
HIV-positive)
12.2% 20.2% 13.7% 29.8% 18.1% 30.4% 32.9% 23.2% 56.0% 35.4% < 0.001
On antiretroviral therapy (of those HIV-
positive)
3.20% 12.0% 5.5% 28.0% 10.9% 15.20% 22.20% 7.70% 51.30% 24.00% < 0.001
Chemsex, taking drugs (typically stimulants) before sex (excluding alcohol).
*v2 test for binary variables, or a t-test for continuous variables, stratified by non-NGO vs. NGO client status across the combined survey year groups.
Table 3 Unadjusted and adjusted odds ratios (with 95% confidence
intervals) from mixed-effect logistic regression* of being a non-
governmental organization (NGO) client for various demographic
characteristics
Odds ratio (95% confidence interval)
Outcome variable: NGO client Unadjusted
Adjusted
(N = 18 277)
HIV-positive 1.67 (1.44–1.93) 1.61 (1.39–1.86)
Age (continuous, per 10-year
increase)
1.13 (1.09–1.18) 1.07 (1.03–1.12)
Ever imprisoned 0.90 (0.74–1.08) 1.01 (0.83–1.23)
Transgender 1.28 (1.05–1.57) 1.35 (1.10–1.67)
Provided sex for money in last
6 months
0.95 (0.84–1.07) 1.04 (0.92–1.19)
Had sex with a woman in last
6 months
0.56 (0.51–0.61) 0.55 (0.50–0.60)
Total anal sex contacts last month 1.00 (0.99–1.01) 1.00 (0.99–1.01)
Education
Incomplete secondary 1 1
Complete secondary 1.06 (0.80–1.40) 1.07 (0.81–1.43)
Vocational secondary 1.98 (1.52–2.57) 1.95 (1.49–2.55)
Incomplete higher 2.06 (1.58–2.69) 2.04 (1.55–2.68)
Higher 2.34 (1.80–3.04) 2.25 (1.71–2.95)
Scientific degree 2.60 (1.70–3.98) 2.59 (1.67–4.01)
*With year and city as the crossed random effects and excluding the
2011 data, as the question on being transgender was not included.
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Cascade of care
The HIV cascades of care among MSM in Ukraine for
2011 and 2018 split by NGO client status are shown in
Fig. 2. In 2018, a higher proportion of HIV-positive NGO
clients than non-NGO clients were aware of their HIV sta-
tus, self-reported being registered at an AIDS centre, and
were on ART (all P < 0.001). Better outcomes were also
seen for NGO clients for each stage of the cascade of care
in 2011. Between 2011 and 2018, the outcomes improved
for both NGO and non-NGO clients; however, the differ-
ences between the two groups also increased.
Discussion
Our analyses of data from four national IBBSs of MSM in
Ukraine spanning 2011–2018 show that being a client of
an NGO is associated with consistently better preventive,
Fig. 1 Adjusted* odds ratios (with 95% confidence intervals) for various outcomes from being a non-governmental organization (NGO) client
vs. not being a NGO client, using mixed-effect logistic regression. *, adjusted for age, ever imprisoned, higher education, total anal sex con-
tacts in last month, having had sex with a woman in last 6 months, group sex in the last 6 months, chemsex in the last 30 days, being trans-
gender, and having provided sex for money in the last 6 months, with city and year as crossed-effects; **, condom for last anal intercourse;
***, either bought condoms last month or received condoms last year. SR, self-reported; ART, antiretroviral therapy; ‘among HIV-positive/nega-



























































Reg AIDS centre On ART
Non−NGO NGO
Test HIV-positive Aware HIV-positive
Fig. 2 HIV cascade of care among all HIV-positive men who have sex with men (MSM) for 2011 (left) and 2018 (right), stratified by whether
they are non-governmental organization (NGO) clients or not, with tests for differences in proportions across groups. ‘Reg’, ‘registered at’; ART,
antiretroviral therapy.
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HIV testing and HIV treatment outcomes. First, MSM who
were clients of NGOs were more likely than those who were
not clients to have received condoms (freely or bought)
and to have used a condom for their last anal intercourse.
Second, each step of the HIV cascade of care was better
among clients of NGOs. They were more likely to have ever
been tested for HIV and to have been tested in the previous
year. If they were HIV-positive, they were more likely to be
aware of their status, to be registered at an AIDS centre,
and to self-report being on ART than their non-NGO client
counterparts. Third, NGO clients were more likely to have
heard of PrEP and to have used PrEP in the past year,
although coverage was low. They were also more likely to
be HIV-positive, to be better educated, transgender, and to
not report recently having a female sex partner. It is likely
that NGOs target and attract HIV-positive MSM because of
their provision of MSM-friendly HIV testing and follow-on
support for accessing HIV care. This possibly accounts for
why NGO clients were more likely to be HIV-positive than
non-NGO clients.
Evidence suggested that although coverage of NGOs
remained stable over time, the percentage of HIV-positive
MSM registered in AIDS centres and on ART increased
over time, as did the percentage of MSM ever tested for
HIV. Conversely, the overall levels of condom use
remained stable, while HIV prevalence also remained
stable over time, among both all MSM and those
aged < 25 years, suggesting that HIV incidence has not
decreased over this time period.
Comparison with other literature
To our knowledge, no other studies from Ukraine have
looked at associations between NGO intervention contact
among MSM and how that affects risk behaviours, the HIV
cascade of care and uptake of condoms. We have looked at
a similar issue among people who inject drugs in Ukraine
and found similarly consistent beneficial associations of
contact with NGOs [20]. Overall, there has been limited
research on the HIV epidemic among MSM in Ukraine.
Another study using IBBS data reported, in agreement with
our study, that contact with NGOs was associated with
reductions in unprotected anal intercourse among MSM
[21]. Similar to our findings, other studies of multiple IBBS
rounds have found stable HIV prevalence over time among
MSM [22,23]. Another study of MSM in Kiev found a HIV
prevalence of 24.1% in 2014 [24]; this was higher than the
prevalence we found among MSM in Kiev (10.8%), possibly
due to a misclassification of low-risk MSM as heterosexu-
als, leading to an elevated prevalence among those cap-
tured, which has been reported in other studies [25].
Globally, few studies have considered the impact of
national-scale HIV programmes for MSM on individual-
level HIV prevention and treatment outcomes. One large-
scale study utilizing a national IBBS of MSM
(n ~ 10 000) in India found that increased numbers of
integrated counselling and testing centres in an area led
to higher levels of awareness of HIV status [26], while
contact with these centres increased HIV testing [27].
Other earlier studies in southern India (also utilizing
large-scale surveys) showed that the Avahan HIV preven-
tion intervention for MSM (and female sex workers)
increased condom use in MSM, averted considerable
infections and was cost-effective [28]. Otherwise, much
smaller subnational studies among MSM (n ~ 500–1000)
have shown that contact with drop-in centres is associ-
ated with increased HIV testing in Myanmar [29], while
scale-up of prevention activities in Senegal may have
increased condom use and reduced sexually transmitted
infections [30]. This illustrates how our large national-
scale multi-round analysis among MSM in Ukraine is rel-
atively unique in the HIV literature at the individual
level, particularly for eastern Europe and Central Asia.
Strengths and limitations
Our analyses’ main strengths include using multiple
national-level IBBS that have large sample sizes, span
many years and ask comparable questions over the sur-
veys. The surveys considered diverse topics, allowing
examination of varied outcomes. Our findings give a con-
sistent picture that contact with HIV prevention NGOs is
associated with beneficial outcomes. Our use of survey
data across 26–28 cities in Ukraine, covering all regions,
means that the results should be generalizable to the
national level. However, around 90% of the participants
of these surveys were aged < 40 years, which is probably
younger than the age profile of MSM at a national level,
which should more closely match that of the general
population where around 45% of adult males are aged <
40. Regarding education, a similar percentage of males in
the survey had higher education (33%) as in the general
population aged 15–40 (28%) [31].
As the study is observational, we were limited to look-
ing at associations rather than causation. It is possible
that those in contact with NGOs are also more likely to
have more positive health-seeking behaviours than non-
NGO clients. Although most questions were the same or
similar across years, some changed or were unavailable
for particular years. This did not generally affect our
analyses. Also, while most major cities/regions were sam-
pled in all IBBSs, some (3/28) were omitted for certain
© 2020 The Authors.
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rounds. HIV viral load was only tested among a subsam-
ple of HIV-positive MSM in later surveys to help estimate
incidence and therefore could not be used as a biological
marker of successful ART uptake; self-reported ART
uptake measures can be problematic [32]. Assessing
trends over a limited number of time points can some-
times cause difficulties with interpretation if some esti-
mates appear to be outliers. This was the case for
estimates of ART coverage in 2015, which differ from
other years. The reasons for this are uncertain but could
be due to chance because of the small number of MSM
testing or self-reporting as HIV-positive used as the
denominator. Further rounds should help clarify trends.
While the results for HIV infection were based on bio-
logical testing, all other data on behaviours and interven-
tions were self-reported and could therefore be affected
by varying levels of bias. This is a common weakness in
these types of analysis based on bio-behavioural survey
data. Recall bias could be an issue due to the surveys
asking questions about behaviours over several months,
while participants could also answer questions in ways
they deem desirable to those asking the questions (social
desirability bias), which could lead to a systematic under-
estimation of harmful practices. It is unclear whether this
would affect NGO and non-NGO clients differentially;
however, there is a possibility that, as some of the sur-
veys were carried out in the offices of NGOs, clients
would report outcomes that NGOs (the harm reduction
providers) would want to hear – an information bias.
Implications and conclusions
Ukraine’s HIV epidemic is the second largest in Europe
[4], with MSM making up a sizeable portion of the coun-
try’s epidemic [5]. Our findings show that contact with
NGOs within Ukraine is associated with beneficial out-
comes for MSM through receipt of more condoms,
increased HIV testing and improved linkage to HIV treat-
ment, thus suggesting a positive impact of harm reduc-
tion programming, although these analyses cannot prove
causation. To halt the HIV epidemic in Ukraine, as recom-
mended by UNAIDS’ ambitious elimination targets [33], it
is paramount that MSM are put on ART while condom
use is maximized for reducing transmission. From Octo-
ber 2020, the US Centres for Disease Control will support
NGOs to start providing ART. This follows a 2018 report
by Deloitte suggesting that NGOs should have an
expanded role in providing HIV care [34]. However, cur-
rent data suggest that HIV prevalence and incidence are
not decreasing among MSM in Ukraine, indicating that
more effort is needed to improve current levels of HIV
treatment and condom use. Our analyses suggest that this
could be achieved through scaling up the coverage of
MSM NGOs, which currently only reach about a third of
MSM according to our study. Unfortunately, this could be
a difficult task because Ukraine is currently experiencing
a decrease in Global Fund monetary support [13], has
only recently emerged from economic recession, is still
engaged in a war with Russia [14,35], and is likely to
experience a further economic downturn due to the
ongoing COVID-19 pandemic [36]. Despite these issues,
it is crucial that Ukrainian policy-makers ensure
funding for MSM interventions is not reduced, but
rather increased, to have greater public health benefits
[37] as achieved in other MSM HIV epidemics [38,39].
As in these settings, consideration should also be made
to introducing PrEP, which could have a dramatic
effect on reducing HIV acquisition [7]; a pilot interven-
tion in Kyiv has shown the feasibility of such an
intervention [40].
Acknowledgements
We would like to thank all the people who participated in
the surveys used in this paper and those who collected
the data, including the Global Fund to Fight AIDS, Tuber-
culosis and Malaria and the US Centers for Disease Con-
trol (CDC), which funded the surveys.
Conflict of interest: NS, TS, YS and OV work for the
Alliance for Public Health (APH), Ukraine, which is a
non-governmental organization. The Global Fund to
Fight AIDS, Tuberculosis and Malaria (GF) or other inter-
national funders had no role in these analyses or in deci-
sions to publish. APH is one of the largest recipients in
Ukraine of funding from the GF, and the salaries of YS
and TS are funded through GF grants. JS reports non-fi-
nancial support from Gilead Sciences, outside the submit-
ted work. JGW reports previous grants from the CDC
Foundation and a current research grant from Gilead
unrelated to this work. PV has received unrestricted
research grants from Gilead unrelated to this work.
Financial disclosure: This work was supported by the
APH, Ukraine, via the Global Fund to Fight AIDS, Tuber-
culosis and Malaria. PV is supported by the UK National
Institute for Health Research (NIHR), Health Protection
Research Unit (HPRU) in Evaluation of Interventions at
the University of Bristol. PV and AGL also acknowledge
funding from NIAID and NIDA (R01AI147490 and
R01DA033679), with JS also acknowledging support from
NIDA (R01DA033679). The 2009–2013 IBBSs were funded
by the Global Fund to Fight AIDS, Tuberculosis and
Malaria and those from 2015-2017 by the CDC.
© 2020 The Authors.
HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association
HIV Medicine (2020)
Ukraine NGOs for MSM and HIV prevention 9
Author contributions
All authors contributed to the study and/or manuscript
writing and provided their approval to submit. PV had
the original idea for the manuscript. AT performed the
analyses and drafted the manuscript with guidance from
AGL, JGW, J, and PV. NS, TS, YS and OV assisted with
the interpretation of results.
References
1 Beyrer C, Baral SD, van Griensven F et al. Global
epidemiology of HIV infection in men who have sex with
men. Lancet 2012; 380: 367–377.
2 UNAIDS. Global AIDS Update 2016. 2016.
3 UNAIDS. UNAIDS Data 2018. 2018.
4 ECDC. HIV/AIDS surveillance in Europe. 2018.
5 Avert. HIV and AIDS in Ukraine 2018. Available at: https://
www.avert.org/professionals/hiv-around-world/eastern-
europe-central-asia/ukraine.
6 UNAIDS. UNAIDS Data 2017. 2017.
7 Molina JM, Capitant C, Spire B et al. On-demand preexposure
prophylaxis in men at high risk for HIV-1 infection. N Engl J
Med 2015; 373: 2237–2246.
8 Foss AM, Watts CH, Vickerman P, Heise L. Condoms and
prevention of HIV. BMJ 2004; 329: 185–186.
9 Cohen MS, Chen YQ, McCauley M et al. Antiretroviral
therapy for the prevention of HIV-1 transmission. New Engl J
Med 2016; 375: 830–839.
10 Trickey A, May MT, Vehreschild JJ et al. Survival of HIV-
positive patients starting antiretroviral therapy between 1996
and 2013: a collaborative analysis of cohort studies. Lancet
Hiv. 2017; 4: E349–E356.
11 Seyler C, Messou E, Gabillard D, Inwoley A, Alioum A,
Anglaret X. Morbidity before and after HAART
initiation in sub-Saharan African HIV-infected adults: a
recurrent event analysis. Aids Res Hum Retrov 2007; 23:
1338–1347.
12 The Global Fund. Global fund grants to Ukraine. Geneva,
Switzerland, The Global Fund, 2018.
13 PEPFAR. Ukraine Country Operational Plan (COP) 2018 -
Strategic Direction Summary 2018.
14 Clark D. Ukraine’s economy has turned a corner. The
Financial Times, 2017. 05/07/2017.
15 Alliance for Public Health. Analytical report: Monitoring of
behaviour and HIV prevalence among men having sex with
men (national part). 2017.
16 Alliance for Public Health. Behavior monitoring of men
having sex with men as a component of second generation
surveillance. 2019.
17 International HIV/AIDS Alliance in Ukraine. Analytical
report: Behaviour monitoring and HIV-prevalence among
men who have sex with men as a component of second
generation surveillance. 2012.
18 International HIV/AIDS Alliance in Ukraine. Summary of the
analytical report: Monitoring the behaviour and HIV-
infection prevalence among men who have sex with men as
a component of HIV second generation surveillance. 2014.
19 Avery L, Rotondi N, McKnight C, Firestone M, Smylie J,
Rotondi M. Unweighted regression models perform better
than weighted regression techniques for respondent-driven
sampling data: results from a simulation study. BMC Med
Res Methodol 2019; 19: 202.
20 Trickey A, Semchuk N, Saliuk T et al. Has Global Fund
resourcing of non-governmental organisations in Ukraine
improved HIV prevention and treatment outcomes for people
who inject drugs? J Int AIDS Soc 2020; 23: e25608.
21 Iakunchykova O, Burlaka V, King EJ. Correlates of
serosorting and knowledge of sexual partner’s HIV status
among men who have sex with men in Ukraine. Aids Behav
2018; 22: 1955–1964.
22 Dumchev K, Sazonova Y, Salyuk T, Varetska O. Trends in
HIV prevalence among people injecting drugs, men having
sex with men, and female sex workers in Ukraine. Int J Std
Aids 2018; 29: 1337–1344.
23 Vitek CR, Cakalo JI, Kruglov YV et al. Slowing of the HIV
epidemic in Ukraine: evidence from case reporting and key
population surveys, 2005–2012. PLoS One 2014; 9: e103657.
24 Simmons R, Malyuta R, Chentsova N et al. HIV testing and
diagnosis rates in Kiev, Ukraine: April 2013-March 2014.
PLoS One 2015; 10: e0137062.
25 Spindler H, Salyuk T, Vitek C, Rutherford G. Underreporting
of HIV transmission among men who have sex with men in
the Ukraine. Aids Res Hum Retrov 2014; 30: 407–408.
26 Mehta SH, Lucas GM, Solomon S et al. HIV care continuum
among men who have sex with men and persons who inject
drugs in India: barriers to successful engagement. Clin Infect
Dis 2015; 61: 1732–1741.
27 Solomon SS, Solomon S, McFall AM et al. Integrated HIV
testing, prevention, and treatment intervention for key
populations in India: a cluster-randomised trial. Lancet HIV
2019; 6: e283–e296.
28 Ramanathan S, Deshpande S, Gautam A et al. Increase in
condom use and decline in prevalence of sexually
transmitted infections among high-risk men who have sex
with men and transgender persons in Maharashtra, India:
Avahan, the India AIDS Initiative. BMC Public Health 2014;
14: 784.
29 Pham MD, Aung PP, Paing AK et al. Factors associated with
HIV testing among young men who have sex with men in
Myanmar: a cross-sectional study. J Int AIDS Soc 2017; 20:
e25026.
30 Wade AS, Larmarange J, Diop AK et al. Reduction in risk-
taking behaviors among MSM in Senegal between 2004 and
© 2020 The Authors.
HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association
HIV Medicine (2020)
10 A Trickey et al.
2007 and prevalence of HIV and other STIs. ELIHoS Project,
ANRS 12139. Aids Care 2010; 22: 409–414.
31 Ukraine SSCo. All-Ukrainian population census 2001. State
Statistics Service of Ukraine. 2001.
32 Wilson IB, Carter AE, Berg KM. Improving the self-report of
HIV antiretroviral medication adherence: is the glass half full
or half empty? Curr HIV/AIDS Rep 2009; 6: 177–86.
33 UNAIDS. 90–90-90 An ambitious treatment target to help
end the AIDS epidemic. 2017.
34 Deloitte LA, Dierst-Davies R, Sereda Y et al. HIV investment case
study for Ukraine: Evaluation of program costs, service quality,
and resource allocation for HIV expenditure in 2015. 2018.
35 Vasylyeva TI, Liulchuk M, Friedman SR et al. Molecular
epidemiology reveals the role of war in the spread of HIV in
Ukraine. Proc Natl Acad Sci USA 2018; 115: 1051–1056.
36 Organisation for Economic Co-operation and Development.
The COVID-19 crisis in Ukraine. 2020. 29/05/2020.
37 Rutstein SE, Ananworanich J, Fidler S et al. Clinical and public
health implications of acute and early HIV detection and
treatment: a scoping review. J Int AIDS Soc. 2017; 20: 21579.
38 Nwokolo N, Hill A, McOwan A, Pozniak A. Rapidly declining
HIV infection in MSM in central London. Lancet HIV 2017;
4: E482–E483.
39 Medland NA, Chow EPF, Read THR et al. Incident HIV
infection has fallen rapidly in men who have sex with men
in Melbourne, Australia (2013–2017) but not in the newly-
arrived Asian-born. BMC Infect Dis 2018; 18: 410.
40 Klepikov A. Health. AfP. PrEP Experience in Ukraine. IAS
Educational Fund meeting; 20/06/2019; Tbilisi, Georgia,
2019.
Supporting Information
Additional supporting information may be found online
in the Supporting Information section at the end of the
article.
Table S1 Behaviours and preventive outcomes among
men who have sex with men across each survey year,
with respondent-driven sampling weights.
Table S2 Unadjusted and adjusted odds ratios (with
95% confidence intervals) from mixed-effect logistic
regression* for various intervention-related outcomes
from being an NGO client vs. not being an NGO client –
the adjusted results correspond to Fig. 1.
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